Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 40, Issue 8, 1997, Pages 1429-1435

  Llorente, Luis ^a   Richaud Patin, Yvonne ^a   Couderc, Jacques ^b   Alarcon Segovia, Donato ^a   Ruiz Soto, Rodrigo ^a   Alcocer Castillejos, Natasha ^a   Alcocer Varela, Jorge ^a   Granados, Julio ^a   Bahena, Susana ^a   Galanaud, Pierre ^b   Emilie, Dominique ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b Institut Paris Sud sur les Cytokines   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PRIORITY JOURNAL; RELATIVE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGE FACTORS; ANTIBODY FORMATION; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; FAMILY HEALTH; FEMALE; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MONOCYTES; SEX FACTORS;

EID: 0030924069     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400810     Document Type: Article

References (35)

1. Klinman DM, Steinberg AD: Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165:1755-1760, 1987
2. Block SR, Gibbs CB, Stevens MB, Shulman LE: Delayed hypersensitivity in systemic lupus erythematosus. Ann Rheum Dis 27:311-318, 1968
3. Alcocer-Varela J, Laffon A, Alarcon-Segovia D: Defective monocyte production of, and T lymphocyte response to, interleukin-1 in the peripheral blood of patients with systemic lupus erythematosus. Clin Exp Immunol 54:125-132, 1983
4. Alcocer-Varela J, Alarcon-Segovia D: Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 69:1388-1392, 1982
5. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz D: Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 130:2651-2655, 1983
6. Morimoto C, Steinberg AD, Letvin NL, Hagan M, Takeuchi T, Daley J, Levine H, Schlossman SF: A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J Clin Invest 79:762-768, 1987
7. Via GS, Tsokos GC, Bermas B, Clerici M, Shearer GM: T cell-antigen-presenting cell interactions in human systemic lupus erythematosus: evidence for heterogeneous expression of multiple defects. J Immunol 151:3914-3922, 1993
8. Rousset F, Garcia E, Defrance T, Peronne C, Hsu DH, Kastelein R, Moore KW, Banchereau J: Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 89:1890-1893, 1992
9. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Morel-Fourrier B, Brouet JC, Alarcon-Segovia D, Galanaud P, Emilie D: Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839-844, 1995
10. De Waal Malefyt R, Yssel H, de Vries JE: Direct effect of IL-10 on subsets of human CD4+ T cells clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 150:4754-4765, 1993
11. Enk AH, Angeloni VL, Udey MC, Katz SI: Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 151:2390-2398, 1993
12. Howard M, O'Garra A: Biological properties of interleukin 10. Immunol Today 6:198-200, 1992
13. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Morel-Fourrier B, Galanaud P, Emilie D: Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4:421-430, 1993
14. Llorente L, Richaud-Patin Y, Fior R, Alcocer-Varela J, Wijdenes J, Morel Fourrier B, Galanaud P, Emilie D: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647-1655, 1994
15. Hagiwara E, Gourley MF, Lee S, Klinman DM: Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 39:379-385, 1996
16. Houssiau FA, Lefebvre C, van den Berghe M, Lambert M, Devogelaer J-P, Renauld J-J: Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 4:393-395, 1995
17. Al-Janadi M, Al-Dalaan A, Al-Balla S, Al-Humaidi M, Raziuddin S: Interleukin-10 secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10-dependent CD4+CD45RO+ T cell-B-cell antibody synthesis. J Clin Immunol 16:198-207, 1996
18. Miles S, Isenberg D: A review of serological abnormalities in relatives of SLE patients. Lupus 2:145-150, 1993
19. Sakane T, Murakawa Y, Suzuki N, Ueda Y, Tsuchida T, Takada S, Yamauchi Y, Tsunematsu T: Familial occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus. Am J Med 86:385-390, 1989
20. Clark J, Bourne T, Salaman MR, Seifert MH, Isenberg DA: B lymphocyte hyperactivity in families of patients with systemic lupus erythematosus. J Autoimmun 9:59-65, 1996
21. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
22. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M: Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22:711-717, 1992
23. Perez L, Orte J, Brieva JA: Terminal differentiation of spontaneous rheumatoid factor-secreting B cells from rheumatoid arthritis patients depends on endogenous interleukin-10. Arthritis Rheum 38:1771-1776, 1995
24. Kotzin BL: Systemic lupus erythematosus. Cell 85:303-306, 1996
25. Theofilopoulos AN: The basis of autoimmunity. Part II. Genetic disposition. Immunol Today 16:150-159, 1995
26. Granados J, Vargas-Alarcón G, Andrade F, Melin-Aldana H, Alcocer-Varela J, Alarcón-Segovia D: The role of HLA-DR alleles and complotypes through the ethnic barrier in systemic lupus erythematosus in Mexicans. Lupus 5:184-189, 1996
27. Huang D-F, Siminovitch KA, Liu X-Y, Olee T, Olsen NJ, Berry C, Carson DA, Chen PP: Population and family studies of three disease-related polymorphic genes in systemic lupus erythematosus. J Clin Invest 95:1766-1772, 1995
28. Kumar A, Martinez-Tarquino C, Maria-Forte A, Kumar P, Alarcon-Segovia D, Granados J, Pandey JP, Buxbaum J, Schur PH: Immunoglobulin heavy chain constant-region gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 34:1553-1556, 1991
29. Tebib JG, Alcocer-Varela J, Alarcon-Segovia D, Schur P: Association between a T cell receptor restriction fragment length polymorphism (RFLP) and systemic lupus erythematosus. J Clin Invest 86:1961-1967, 1990
30. Tountas NA, Cominelli F: Identification and initial characterization of two polymorphisms in the human interleukin-10 promoter (abstract). Eur Cytokine Netw 7:578, 1996
31. Eskdale J, Wordsworth P, Field M, Gallagher G: Distribution of IL-10 promoter microsatellite alleles in systemic lupus erythematosus and rheumatoid arthritis (abstract). Arthritis Rheum 39 (suppl 9):S127, 1996
32. Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN: Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A 91:10168-10172, 1994
33. 1 mice. J Exp Med 179:305-310, 1994
34. Ishida H, Hastings R, Kearney J, Howard M: Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells but not conventional B cells. J Exp Med 175:1213-1220, 1992
35. Nisitani S, Tsubata T, Murakami M, Honjo T: Administration of interleukin-5 or -10 activates peritoneal B-1 cells and induces autoimmune hemolytic anemia in anti-erythrocyte autoantibody-transgenic mice. Eur J Immunol 25:3047-3052, 1995